EUVIMEDEUVIMED entdecken
KommentarOpen Access · CC BY 4.0

Case Commentary: When susceptibility is not enough in recurrent Burkholderia cenocepacia infection

Simone Giuliano, Paolo Gaibani iD, Carlo Tascini iD

Antimicrobial Agents and Chemotherapy · 01.07.2026 · 70 (7)

DOI: 10.1128/aac.00467-26 ↗

Kurz gefasst

Kommentar in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 01.07.2026. Verfasst von Simone Giuliano und 2 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Unit, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Burkholderia cenocepacia, Burkholderia Infections, Cephalosporins. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this issue, B. Gaglani, T. M. Andermann, C. Wate, J. Oldan, et al. (Antimicrob Agents Chemother 70:e01542-25, 2026, https://doi.org/10.1128/aac.01542-25 ) describe a recurrent Burkholderia cenocepacia infection successfully treated with cefiderocol plus sulbactam-durlobactam. Treatment decisions are often made with incomplete microbiological and pharmacological data, even as interest in mechanism-based β-lactam combination strategies continues to grow. This case supports the utility of cefiderocol plus sulbactam-durlobactam in B. cenocepacia infection and reinforces the importance of multidisciplinary approaches to better estimate the risk of treatment failure and optimize antimicrobial therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsBurkholderia cenocepaciaBurkholderia InfectionsCephalosporinsHumansCefiderocolDrug CombinationsMicrobial Sensitivity TestsSulbactamCase Reports as Topic

Stichwörter der Autor:innen

Burkholderia cenocepaciaantimicrobial susceptibility testingcefiderocolcystic fibrosispenicillin-binding proteinssulbactam-durlobactamβ-lactam combination therapy

Substanzen

Anti-Bacterial AgentsCefiderocolCephalosporinsDrug CombinationsSulbactam

Autor:innen und Institutionen

  • Infectious Diseases Unit, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
  • Department of Diagnostic and Public Health, Microbiology Section, Verona University, Verona, Italy.
  • Microbiology and Virology Unit, Department of Pathology, Azienda Ospedaliera Universitaria Integrata Di Verona, Verona, Italy.
  • Department of Medicine, DMED University of Udine, Udine, Italy.

ORCID-Profile: Paolo Gaibani, Carlo Tascini

Zitieren

APA

Giuliano, S., Gaibani, P., & Tascini, C. (2026). Case Commentary: When susceptibility is not enough in recurrent Burkholderia cenocepacia infection. Antimicrobial Agents and Chemotherapy, 70(7). https://doi.org/10.1128/aac.00467-26

Vancouver

Giuliano S, Gaibani P, Tascini C. Case Commentary: When susceptibility is not enough in recurrent Burkholderia cenocepacia infection. Antimicrobial Agents and Chemotherapy. 2026;70(7). doi:10.1128/aac.00467-26

BibTeX
@article{Giuliano2026,
  author = {Giuliano, Simone and Gaibani, Paolo and Tascini, Carlo},
  title = {Case Commentary: When susceptibility is not enough in recurrent Burkholderia cenocepacia infection},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  volume = {70},
  number = {7},
  doi = {10.1128/aac.00467-26}
}
Kostenlos starten →